ZA986475B - Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it. - Google Patents

Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.

Info

Publication number
ZA986475B
ZA986475B ZA9806475A ZA986475A ZA986475B ZA 986475 B ZA986475 B ZA 986475B ZA 9806475 A ZA9806475 A ZA 9806475A ZA 986475 A ZA986475 A ZA 986475A ZA 986475 B ZA986475 B ZA 986475B
Authority
ZA
South Africa
Prior art keywords
carbazoly
propanole
loxy
methoxyphenoxy
ethylamino
Prior art date
Application number
ZA9806475A
Other languages
English (en)
Inventor
Erhard Reinholz
Peter Beyer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of ZA986475B publication Critical patent/ZA986475B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9806475A 1997-07-22 1998-07-21 Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it. ZA986475B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97112491A EP0893440A1 (en) 1997-07-22 1997-07-22 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
ZA986475B true ZA986475B (en) 2000-01-21

Family

ID=8227094

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9806475A ZA986475B (en) 1997-07-22 1998-07-21 Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.

Country Status (32)

Country Link
EP (2) EP0893440A1 (xx)
JP (1) JP2001510824A (xx)
KR (1) KR100336229B1 (xx)
CN (1) CN1125047C (xx)
AR (1) AR015133A1 (xx)
AT (1) ATE236123T1 (xx)
AU (1) AU740453B2 (xx)
BR (1) BR9810776A (xx)
CA (1) CA2296637C (xx)
CZ (1) CZ296947B6 (xx)
DE (1) DE69812964T2 (xx)
DK (1) DK1000027T3 (xx)
ES (1) ES2195366T3 (xx)
HK (1) HK1029339A1 (xx)
HR (1) HRP980406A2 (xx)
HU (1) HUP0003198A3 (xx)
IL (1) IL133677A (xx)
MA (1) MA26523A1 (xx)
MY (1) MY117734A (xx)
NO (1) NO313588B1 (xx)
NZ (1) NZ502136A (xx)
PE (1) PE96999A1 (xx)
PL (1) PL191602B1 (xx)
PT (1) PT1000027E (xx)
RU (1) RU2202542C2 (xx)
SI (1) SI1000027T1 (xx)
TR (1) TR200000148T2 (xx)
TW (1) TW505631B (xx)
UY (1) UY25108A1 (xx)
WO (1) WO1999005105A1 (xx)
YU (1) YU2200A (xx)
ZA (1) ZA986475B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2402336C (en) * 2000-04-03 2008-03-11 F. Hoffmann-La Roche Ag Concentrated solutions of carvedilol
EP1655285A1 (en) * 2000-06-28 2006-05-10 Teva Pharmaceutical Industries Ltd. Method for preparation of a crystalline form of carvedilol (form II)
CN1245974C (zh) * 2000-06-28 2006-03-22 特瓦制药工业有限公司 卡维地洛
AU2002326391A1 (en) * 2001-07-13 2003-01-29 Smithkline Beecham Corporation Carvedilol polymorph
WO2003024426A1 (en) 2001-09-21 2003-03-27 Egalet A/S Controlled release solid dispersions
CN1308307C (zh) * 2001-09-28 2007-04-04 弗·哈夫曼-拉罗切有限公司 假多晶型的卡维地洛
MXPA04006909A (es) 2002-01-15 2005-04-19 Teva Pharma Solidos cristalinos de carvedilol y procesos para su preparacion.
US20050148779A1 (en) * 2002-04-30 2005-07-07 Wei Chen Carvedilol monocitrate monohydrate
CA2492084A1 (en) 2002-06-27 2004-01-08 Sb Pharmco Puerto Rico Inc. Carvedilol hydobromide
CN1678305A (zh) 2002-06-27 2005-10-05 Sb药物波多黎各公司 卡维地洛磷酸盐和/或其溶剂合物和/或相应组合物和/或治疗方法
WO2004041252A1 (en) * 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
WO2004084868A1 (en) 2003-03-26 2004-10-07 Egalet A/S Morphine controlled release system
EP1615888A1 (en) * 2003-04-21 2006-01-18 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
WO2005051383A1 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
DK1838670T3 (da) * 2004-12-09 2010-03-01 Zach System Spa Fremgangsmåde til fremstilling af carvedilol og dets enantiomere
US20070043099A1 (en) * 2005-06-09 2007-02-22 Igor Lifshitz Crystalline forms of carvedilol and processes for their preparation
WO2008002683A2 (en) 2006-06-28 2008-01-03 Teva Pharmaceutical Industries Ltd. Polymorphous forms of carvedilol phosphate
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
CA2687192C (en) 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
IL133677A0 (en) 2001-04-30
WO1999005105A1 (en) 1999-02-04
EP1000027B1 (en) 2003-04-02
UY25108A1 (es) 2000-12-29
DE69812964T2 (de) 2004-03-04
CZ296947B6 (cs) 2006-08-16
PL338432A1 (en) 2000-11-06
CZ2000221A3 (cs) 2000-05-17
JP2001510824A (ja) 2001-08-07
DK1000027T3 (da) 2003-07-21
EP0893440A1 (en) 1999-01-27
SI1000027T1 (en) 2003-10-31
NO20000301D0 (no) 2000-01-21
CN1264366A (zh) 2000-08-23
CN1125047C (zh) 2003-10-22
MY117734A (en) 2004-07-31
IL133677A (en) 2004-06-01
HUP0003198A3 (en) 2002-10-28
ES2195366T3 (es) 2003-12-01
PL191602B1 (pl) 2006-06-30
PE96999A1 (es) 1999-10-12
PT1000027E (pt) 2003-07-31
NO313588B1 (no) 2002-10-28
NZ502136A (en) 2002-05-31
ATE236123T1 (de) 2003-04-15
DE69812964D1 (de) 2003-05-08
AU740453B2 (en) 2001-11-01
CA2296637C (en) 2005-11-15
MA26523A1 (fr) 2004-12-20
CA2296637A1 (en) 1999-02-04
AU8631998A (en) 1999-02-16
YU2200A (sh) 2002-03-18
KR20010022097A (ko) 2001-03-15
KR100336229B1 (ko) 2002-05-09
TW505631B (en) 2002-10-11
BR9810776A (pt) 2000-09-19
EP1000027A1 (en) 2000-05-17
HUP0003198A2 (en) 2001-03-28
TR200000148T2 (tr) 2000-07-21
AR015133A1 (es) 2001-04-18
HK1029339A1 (en) 2001-03-30
NO20000301L (no) 2000-01-21
RU2202542C2 (ru) 2003-04-20
HRP980406A2 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
ZA986475B (en) Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.
ZA985364B (en) Pharmaceutical formulations containing voriconazole.
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
AU1157599A (en) Pyrimidinone compounds and pharmaceutical compositions containing them
ZA988585B (en) Pharmaceutical compositions containing plasma protein.
AU7294098A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
HK1021313A1 (en) Tetrahydrolipstatin containing compositions.
IL136941A0 (en) Sulphonamide derivatives and pharmaceutical compositions containing the same
HUP0200355A3 (en) 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
HUP0000851A3 (en) Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0102372A3 (en) Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same
ZA9710015B (en) Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications.
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
HUP9601328A3 (en) 4-(aryl-amino-methylene)-2,4-dihydro-pyrazol-3-one derivatives and pharmaceutical compositions containing them
AU6120498A (en) 4,4-difluoro-2,3,4,5-tetrahydro-1h-1-benzazepine derivatives and drug compositions containing them
HUP9902138A3 (en) N-[4-(heteroarylmethyl)phenyl]-heteroarylamine derivatives, their preparation and pharmaceutical compositions containing them
IL136937A0 (en) τ-GLUTAMYL AND β-ASPARTYL CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL138725A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
HUP0002853A3 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
ZA983849B (en) Pharmaceutical compositions of tizoxanide and nitazoxanide.
HK1015789A1 (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use.